Is it true that multiple antioxidant therapy may reduce disease progression in early onset PD and increase the time before the L-Dopa drug is needed?
L-Dopa is the mainstay of treatment for advanced PD but severe side effects develop after about 5 years. The reasons for this are not known but it is suspected that L-Dopa generates reactive oxygen species, which cause further damage and produces the side effects. It has been proposed that multiple antioxidant therapy in combination with L-Dopa might reduce these side effects.
